VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TDACWTranslational Development Acquisition Corp.
$1.27$22M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTDACWP/E History

TDACW logoTranslational Development Acquisition Corp. (TDACW) P/E Ratio History

Expensive

Trading at 3.4x vs 5Y avg 1.1x · 92th percentile · Material premium to history · Data 2018–2026

Current P/E (TTM)
3.4x
+202% vs 5Y avg
5Y Avg P/E
1.1x
Median 0.6x
5Y Percentile
92th
Upper end of range
PEG Ratio
N/A
5-Year P/E Range
3.4x
Min0.3xMedian0.6xMax5.1x
TTM EPS$0.36
Price$1.27
Earnings Yield29.13%
EPS Growth (1Y)2384.0%
EPS Growth (5Y)0.5%

Loading P/E history...

P/E Ratio Analysis

As of June 28, 2026, Translational Development Acquisition Corp. (TDACW) trades at a price-to-earnings ratio of 3.4x, with a stock price of $1.27 and trailing twelve-month earnings per share of $0.36.

The current P/E is 202% above its 5-year average of 1.1x. Over the past five years, TDACW's P/E has ranged from a low of 0.3x to a high of 5.1x, placing the current valuation at the 92th percentile of its historical range.

Compared to the Financial Services sector median P/E of 14.2x, TDACW trades at a 76% discount to its sector peers. The sector includes 801 companies with P/E ratios ranging from 0.0x to 157.7x.

Relative to the broader market, TDACW trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TDACW DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

TDACW Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Financial Services
3.4vs14.2
-76%
Below Sector
vs. S&P 500
3.4vs25.3
-86%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 2384% EPS growth (1Y)

TDACW P/E vs Peers

SPACs and acquisition vehicles peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
IQV logoIQVIQVIA Holdings Inc.
$32B24.4Lowest0.60Best+5%
ICLR logoICLRICON Public Limited Company
$13B58.6--70%
MEDP logoMEDPMedpace Holdings, Inc.
$15B34.51.08+21%Best
PRA logoPRAProAssurance Corporation
$1B25.3--4%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

TDACW Historical P/E Data (2018–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$0.12$0.290.4x-63%
FY2025 Q3-$0.29$0.520.6x-51%
FY2025 Q2Jun 30 2025$0.31$0.430.7x-37%
FY2021 Q3-$2.03$1.201.7x+49%
FY2020 Q2-$0.46$0.095.1x+345%
FY2020 Q1-$0.10$0.250.4x-66%
FY2019 Q4-$0.10$0.360.3x-75%
FY2019 Q3Sep 30 2019$0.15$0.450.3x-71%
FY2019 Q2Jun 30 2019$0.15$0.460.3x-71%
FY2019 Q1Mar 31 2019$0.16$0.360.4x-61%
FY2018 Q4Dec 31 2018$0.30$0.251.2x+6%
FY2018 Q3Sep 30 2018$0.29$0.132.2x+96%

Average P/E for displayed period: 1.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TDACW — Frequently Asked Questions

Quick answers to the most common questions about buying TDACW stock.

What is TDACW's P/E ratio?

Translational Development Acquisition Corp. (TDACW) trailing twelve-month P/E ratio is 3.4x, based on TTM diluted EPS of $0.36. The 5-year average P/E is 1.1x and the historical range spans 0.3x to 5.1x.

Is TDACW stock overvalued or undervalued?

TDACW trades at 3.4x P/E, above its 5-year average of 1.1x. The 92th percentile ranking within the 0.3x–5.1x historical range indicates a premium to historical valuation.

Is TDACW stock expensive?

Yes, TDACW is expensive relative to its own history. The current P/E of 3.4x is above the 5-year average of 1.1x. The stock sits at the 92th percentile of its 5-year valuation range.

What is TDACW's historical P/E range?

Over the past 5 years, TDACW's P/E ratio has ranged from 0.3x to 5.1x, with a median of 0.6x and an average of 1.1x. The current P/E of 3.4x places the stock at the 92th percentile of this range. Full historical data spans 2018–2026.

How does TDACW's P/E compare to the S&P 500?

TDACW trades at 3.4x P/E versus the S&P 500 median of 25.3x. The 87% discount to the market suggests lower growth expectations or perceived higher risk.

How does TDACW's valuation compare to Financial Services peers?

Translational Development Acquisition Corp. P/E of 3.4x compares to the Financial Services sector median of 14.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is TDACW's PEG ratio?

TDACW PEG ratio is N/A, based on a P/E of 3.4x and EPS growth of 2384.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is TDACW's earnings yield?

TDACW earnings yield is 29.13%, the inverse of its 3.4x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

TDACW P/E Ratio History (2018–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current0.4x
Period Avg1.1x
Range0.3x - 5.1x
Change-81%
12 quartersSep 30, 2018 - Mar 31, 2026